Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Cannabis cultivation within a religious context: A case study of Ghomara in the Rif Mountain (Northern Morocco).

Yassin M, Haluza-Delay R, Kadiri M, Ouahrani AE, Mesa JM, Merzouki A.

J Ethn Subst Abuse. 2017 Apr 4:1-22. doi: 10.1080/15332640.2017.1300972. [Epub ahead of print]

PMID:
28375809
2.

Comparison of Lamiaceae medicinal uses in eastern Morocco and eastern Andalusia and in Ibn al-Baytar's Compendium of Simple Medicaments (13th century CE).

El-Gharbaoui A, Benítez G, González-Tejero MR, Molero-Mesa J, Merzouki A.

J Ethnopharmacol. 2017 Apr 18;202:208-224. doi: 10.1016/j.jep.2017.03.014. Epub 2017 Mar 18.

PMID:
28323048
3.

The mechanical properties of a cell-based numerical model of epithelium.

Merzouki A, Malaspinas O, Chopard B.

Soft Matter. 2016 May 25;12(21):4745-54. doi: 10.1039/c6sm00106h.

PMID:
27139927
4.

Chitosans for delivery of nucleic acids.

Buschmann MD, Merzouki A, Lavertu M, Thibault M, Jean M, Darras V.

Adv Drug Deliv Rev. 2013 Aug;65(9):1234-70. doi: 10.1016/j.addr.2013.07.005. Epub 2013 Jul 18. Review.

PMID:
23872012
5.

Changes on metabolic parameters induced by acute cannabinoid administration (CBD, THC) in a rat experimental model of nutritional vitamin A deficiency.

El Amrani L, Porres JM, Merzouki A, Louktibi A, Aranda P, López-Jurado M, Urbano G.

Nutr Hosp. 2013 May-Jun;28(3):857-67. doi: 10.3305/nh.2013.28.3.6430.

6.

Immobilized carboxymethylated dextran coatings for enhanced ELISA.

Liberelle B, Merzouki A, De Crescenzo G.

J Immunol Methods. 2013 Mar 29;389(1-2):38-44. doi: 10.1016/j.jim.2012.12.007. Epub 2012 Dec 29.

PMID:
23279947
7.

Adva-27a, a novel podophyllotoxin derivative found to be effective against multidrug resistant human cancer cells.

Merzouki A, Buschmann MD, Jean M, Young RS, Liao S, Gal S, Li Z, Slilaty SN.

Anticancer Res. 2012 Oct;32(10):4423-32.

PMID:
23060568
8.

Relationship between ammonia sensing properties of polyaniline nanostructures and their deposition and synthesis methods.

Kebiche H, Debarnot D, Merzouki A, Poncin-Epaillard F, Haddaoui N.

Anal Chim Acta. 2012 Aug 6;737:64-71. doi: 10.1016/j.aca.2012.06.003. Epub 2012 Jun 14.

PMID:
22769037
9.

Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery.

Alameh M, Dejesus D, Jean M, Darras V, Thibault M, Lavertu M, Buschmann MD, Merzouki A.

Int J Nanomedicine. 2012;7:1399-414. doi: 10.2147/IJN.S26571. Epub 2012 Mar 13.

10.

Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetes.

Jean M, Alameh M, De Jesus D, Thibault M, Lavertu M, Darras V, Nelea M, Buschmann MD, Merzouki A.

Eur J Pharm Sci. 2012 Jan 23;45(1-2):138-49. doi: 10.1016/j.ejps.2011.10.029. Epub 2011 Nov 9.

PMID:
22085632
11.

Excess polycation mediates efficient chitosan-based gene transfer by promoting lysosomal release of the polyplexes.

Thibault M, Astolfi M, Tran-Khanh N, Lavertu M, Darras V, Merzouki A, Buschmann MD.

Biomaterials. 2011 Jul;32(20):4639-46. doi: 10.1016/j.biomaterials.2011.03.010. Epub 2011 Mar 29.

PMID:
21450340
12.

Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of type 2 diabetes.

Jean M, Alameh M, Buschmann MD, Merzouki A.

Gene Ther. 2011 Aug;18(8):807-16. doi: 10.1038/gt.2011.25. Epub 2011 Mar 17.

PMID:
21412280
13.
14.

New ELISA approach based on coiled-coil interactions.

Liberelle B, Bartholin L, Boucher C, Murschel F, Jolicoeur M, Durocher Y, Merzouki A, De Crescenzo G.

J Immunol Methods. 2010 Oct 31;362(1-2):161-7. doi: 10.1016/j.jim.2010.09.027. Epub 2010 Oct 1.

PMID:
20869967
15.

Chitosan-plasmid nanoparticle formulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB or generation of antibodies.

Jean M, Smaoui F, Lavertu M, Méthot S, Bouhdoud L, Buschmann MD, Merzouki A.

Gene Ther. 2009 Sep;16(9):1097-110. doi: 10.1038/gt.2009.60. Epub 2009 May 14.

PMID:
19440230
16.

Assessing changes in pupillary size in Rifian smokers of kif (Cannabis sativa L.).

Merzouki A, Molero Mesa J, Louktibi A, Kadiri M, Urbano GV.

J Forensic Leg Med. 2008 Jul;15(5):335-8. doi: 10.1016/j.jflm.2007.08.001. Epub 2007 Nov 26.

PMID:
18511011
17.
18.

Identification and characterization of a putative baculoviral transcriptional factor IE-1 from Choristoneura fumiferana granulovirus.

Rashidan KK, Nassoury N, Merzouki A, Guertin C.

J Biochem Mol Biol. 2002 Nov 30;35(6):553-61.

PMID:
12470588
19.

Molecular characterization of three new avian infectious bronchitis virus (IBV) strains isolated in Quebec.

Smati R, Silim A, Guertin C, Henrichon M, Marandi M, Arella M, Merzouki A.

Virus Genes. 2002;25(1):85-93.

PMID:
12206312
20.
21.

Hemp (Cannabis sativa L.) and abortion.

Merzouki A, Ed-derfoufi F, Molero Mesa J.

J Ethnopharmacol. 2000 Dec;73(3):501-3. No abstract available.

PMID:
11091005
22.

Contribution to the knowledge of Rifian traditional medicine. II: Folk medicine in Ksar Lakbir district (NW Morocco).

Merzouki A, Ed-derfoufi F, Molero Mesa J.

Fitoterapia. 2000 Jun;71(3):278-307.

PMID:
10844168
24.

Distinct clustering of HIV type 1 sequences derived from injection versus noninjection drug users in Vancouver, Canada.

Estable MC, Merzouki A, Arella M, Sadowski IJ.

AIDS Res Hum Retroviruses. 1998 Jul 1;14(10):917-9. No abstract available.

PMID:
9671221
26.

HIV-1 gp120/160 expressing cells upregulate HIV-1 LTR directed gene expression in a cell line transfected with HIV-1 LTR-reporter gene constructs.

Merzouki A, Patel P, Cassol S, Ennaji M, Tailor P, Turcotte FR, O'Shaughnessy M, Arella M.

Cell Mol Biol (Noisy-le-grand). 1995 May;41(3):445-52.

PMID:
7580840
27.

Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort.

Michael NL, Mo T, Merzouki A, O'Shaughnessy M, Oster C, Burke DS, Redfield RR, Birx DL, Cassol SA.

J Virol. 1995 Mar;69(3):1868-77.

28.

Accurate and differential quantitation of HIV-1 tat, rev and nef mRNAs by competitive PCR.

Merzouki A, Mo T, Vellani N, Pattullo A, Estable M, O'Shaughnessy M, Tsoukas C, Cassol S.

J Virol Methods. 1994 Dec;50(1-3):115-28.

PMID:
7714034
29.

HIV-1 gp120/160 expressing transfected cell clones to evaluate the antibody-dependent cellular cytotoxicity (ADCC) during the course of HIV-1 infection.

Merzouki A, Patel P, Cassol S, O'Shaughnessy M, Gill J, Arella M.

J Virol Methods. 1994 Jun;48(1):9-21.

PMID:
7962264

Supplemental Content

Loading ...
Support Center